Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in PLoS Pathog

Retrieve available abstracts of 80 articles:
HTML format
Text format



Single Articles


    May 2017
  1. KRAMER B, Goeser F, Lutz P, Glassner A, et al
    Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy.
    PLoS Pathog. 2017;13:e1006373.
    PubMed     Text format     Abstract available


  2. SUI Y, Frey B, Wang Y, Billeskov R, et al
    Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.
    PLoS Pathog. 2017;13:e1006395.
    PubMed     Text format     Abstract available


  3. NAKANO Y, Misawa N, Juarez-Fernandez G, Moriwaki M, et al
    HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation.
    PLoS Pathog. 2017;13:e1006348.
    PubMed     Text format     Abstract available


  4. FENNESSEY CM, Pinkevych M, Immonen TT, Reynaldi A, et al
    Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.
    PLoS Pathog. 2017;13:e1006359.
    PubMed     Text format     Abstract available


  5. BRANDENBERG OF, Magnus C, Rusert P, Gunthard HF, et al
    Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.
    PLoS Pathog. 2017;13:e1006313.
    PubMed     Text format     Abstract available


  6. SERRANO-VILLAR S, Sainz T, Ma ZM, Utay NS, et al
    Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naive to Antiretroviral Therapy: A Pilot Randomized Trial.
    PLoS Pathog. 2017;13:e1006368.
    PubMed     Text format     Abstract available


    April 2017
  7. GANDHI RT, McMahon DK, Bosch RJ, Lalama CM, et al
    Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
    PLoS Pathog. 2017;13:e1006285.
    PubMed     Text format     Abstract available


    March 2017
  8. MOUSTAFA A, Xie C, Kirkness E, Biggs W, et al
    The blood DNA virome in 8,000 humans.
    PLoS Pathog. 2017;13:e1006292.
    PubMed     Text format     Abstract available


  9. BUI JK, Sobolewski MD, Keele BF, Spindler J, et al
    Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir.
    PLoS Pathog. 2017;13:e1006283.
    PubMed     Text format     Abstract available


  10. BEAUPARLANT D, Rusert P, Magnus C, Kadelka C, et al
    Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.
    PLoS Pathog. 2017;13:e1006255.
    PubMed     Text format     Abstract available


  11. TENFORDE MW, Scriven JE, Harrison TS, Jarvis JN, et al
    Immune correlates of HIV-associated cryptococcal meningitis.
    PLoS Pathog. 2017;13:e1006207.
    PubMed     Text format    


    February 2017
  12. YODER AC, Guo K, Dillon SM, Phang T, et al
    The transcriptome of HIV-1 infected intestinal CD4+ T cells exposed to enteric bacteria.
    PLoS Pathog. 2017;13:e1006226.
    PubMed     Text format     Abstract available


  13. YASEN A, Herrera R, Rosbe K, Lien K, et al
    Release of HIV-1 sequestered in the vesicles of oral and genital mucosal epithelial cells by epithelial-lymphocyte interaction.
    PLoS Pathog. 2017;13:e1006247.
    PubMed     Text format     Abstract available


  14. EASTERHOFF D, Moody MA, Fera D, Cheng H, et al
    Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
    PLoS Pathog. 2017;13:e1006182.
    PubMed     Text format     Abstract available


  15. BUI JK, Halvas EK, Fyne E, Sobolewski MD, et al
    Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells.
    PLoS Pathog. 2017;13:e1006230.
    PubMed     Text format     Abstract available


  16. IRIMIA A, Serra AM, Sarkar A, Jacak R, et al
    Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.
    PLoS Pathog. 2017;13:e1006212.
    PubMed     Text format     Abstract available


  17. TANWAR HS, Khoo KK, Garvey M, Waddington L, et al
    The thermodynamics of Pr55Gag-RNA interaction regulate the assembly of HIV.
    PLoS Pathog. 2017;13:e1006221.
    PubMed     Text format     Abstract available


  18. HU Y, O'Boyle K, Auer J, Raju S, et al
    Multiple UBXN family members inhibit retrovirus and lentivirus production and canonical NFkappaBeta signaling by stabilizing IkappaBalpha.
    PLoS Pathog. 2017;13:e1006187.
    PubMed     Text format     Abstract available


  19. COMPTON AA, Schwartz O
    They Might Be Giants: Does Syncytium Formation Sink or Spread HIV Infection?
    PLoS Pathog. 2017;13:e1006099.
    PubMed     Text format    


  20. NEIDLEMAN JA, Chen JC, Kohgadai N, Muller JA, et al
    Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells.
    PLoS Pathog. 2017;13:e1006163.
    PubMed     Text format     Abstract available


  21. MAIDJI E, Somsouk M, Rivera JM, Hunt PW, et al
    Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction.
    PLoS Pathog. 2017;13:e1006202.
    PubMed     Text format     Abstract available


    January 2017
  22. HAMMONDS JE, Beeman N, Ding L, Takushi S, et al
    Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1.
    PLoS Pathog. 2017;13:e1006181.
    PubMed     Text format     Abstract available


  23. DORIA-ROSE NA, Altae-Tran HR, Roark RS, Schmidt SD, et al
    Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.
    PLoS Pathog. 2017;13:e1006148.
    PubMed     Text format     Abstract available


  24. VIOLLET C, Davis DA, Tekeste SS, Reczko M, et al
    RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature.
    PLoS Pathog. 2017;13:e1006143.
    PubMed     Text format     Abstract available


  25. OLIVEIRA MF, Chaillon A, Nakazawa M, Vargas M, et al
    Early Antiretroviral Therapy is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
    PLoS Pathog. 2017;13:e1006112.
    PubMed     Text format     Abstract available


  26. WIBMER CK, Gorman J, Ozorowski G, Bhiman JN, et al
    Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
    PLoS Pathog. 2017;13:e1006074.
    PubMed     Text format     Abstract available


  27. WERTHEIM JO, Kosakovsky Pond SL, Forgione LA, Mehta SR, et al
    Social and Genetic Networks of HIV-1 Transmission in New York City.
    PLoS Pathog. 2017;13:e1006000.
    PubMed     Text format     Abstract available


  28. AWASTHI S, Hook LM, Shaw CE, Pahar B, et al
    An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.
    PLoS Pathog. 2017;13:e1006141.
    PubMed     Text format     Abstract available


  29. HEL Z, Xu J, Denning WL, Helton ES, et al
    Dysregulation of Systemic and Mucosal Humoral Responses to Microbial and Food Antigens as a Factor Contributing to Microbial Translocation and Chronic Inflammation in HIV-1 Infection.
    PLoS Pathog. 2017;13:e1006087.
    PubMed     Text format     Abstract available


    December 2016
  30. ROBERTS ER, Carnathan DG, Li H, Shaw GM, et al
    Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques.
    PLoS Pathog. 2016;12:e1006135.
    PubMed     Text format     Abstract available


  31. KHASNIS MD, Halkidis K, Bhardwaj A, Root MJ, et al
    Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer.
    PLoS Pathog. 2016;12:e1006098.
    PubMed     Text format     Abstract available


  32. ADNAN S, Reeves RK, Gillis J, Wong FE, et al
    Persistent Low-Level Replication of SIVDeltanef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.
    PLoS Pathog. 2016;12:e1006104.
    PubMed     Text format     Abstract available


  33. HADDOX HK, Dingens AS, Bloom JD
    Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV's Envelope Protein on Viral Replication in Cell Culture.
    PLoS Pathog. 2016;12:e1006114.
    PubMed     Text format     Abstract available


  34. ERICSEN AJ, Lauck M, Mohns MS, DiNapoli SR, et al
    Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication.
    PLoS Pathog. 2016;12:e1006048.
    PubMed     Text format     Abstract available


  35. MEURIS F, Carthagena L, Jaracz-Ros A, Gaudin F, et al
    The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis.
    PLoS Pathog. 2016;12:e1006039.
    PubMed     Text format     Abstract available


  36. STABELL AC, Hawkins J, Li M, Gao X, et al
    Non-human Primate Schlafen11 Inhibits Production of Both Host and Viral Proteins.
    PLoS Pathog. 2016;12:e1006066.
    PubMed     Text format     Abstract available


    November 2016
  37. BOULLE M, Muller TG, Dahling S, Ganga Y, et al
    HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell.
    PLoS Pathog. 2016;12:e1005964.
    PubMed     Text format     Abstract available


  38. NIKOLOVA M, Wiedemann A, Muhtarova M, Achkova D, et al
    Subset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV Infection.
    PLoS Pathog. 2016;12:e1005995.
    PubMed     Text format     Abstract available


  39. DUENAS-DECAMP M, Jiang L, Bolon D, Clapham PR, et al
    Saturation Mutagenesis of the HIV-1 Envelope CD4 Binding Loop Reveals Residues Controlling Distinct Trimer Conformations.
    PLoS Pathog. 2016;12:e1005988.
    PubMed     Text format     Abstract available


  40. LESLIE GJ, Wang J, Richardson MW, Haggarty BS, et al
    Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus.
    PLoS Pathog. 2016;12:e1005983.
    PubMed     Text format     Abstract available


  41. SMITH SA, Burton SL, Kilembe W, Lakhi S, et al
    Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth.
    PLoS Pathog. 2016;12:e1005989.
    PubMed     Text format     Abstract available


  42. WHITE CH, Moesker B, Beliakova-Bethell N, Martins LJ, et al
    Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.
    PLoS Pathog. 2016;12:e1006026.
    PubMed     Text format     Abstract available


  43. PRODGER JL, Gray RH, Shannon B, Shahabi K, et al
    Chemokine Levels in the Penile Coronal Sulcus Correlate with HIV-1 Acquisition and Are Reduced by Male Circumcision in Rakai, Uganda.
    PLoS Pathog. 2016;12:e1006025.
    PubMed     Text format     Abstract available


  44. LIN Z, Cantone J, Lu H, Nowicka-Sans B, et al
    Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors.
    PLoS Pathog. 2016;12:e1005990.
    PubMed     Text format     Abstract available


    October 2016
  45. MILES B, Miller SM, Folkvord JM, Levy DN, et al
    Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection.
    PLoS Pathog. 2016;12:e1005924.
    PubMed     Text format     Abstract available


  46. WITTKOPP CJ, Adolph MB, Wu LI, Chelico L, et al
    A Single Nucleotide Polymorphism in Human APOBEC3C Enhances Restriction of Lentiviruses.
    PLoS Pathog. 2016;12:e1005865.
    PubMed     Text format     Abstract available


  47. SUTTIPRAPA S, Rinaldi G, Tsai IJ, Mann VH, et al
    HIV-1 Integrates Widely throughout the Genome of the Human Blood Fluke Schistosoma mansoni.
    PLoS Pathog. 2016;12:e1005931.
    PubMed     Text format     Abstract available


    September 2016
  48. POLICICCHIO BB, Xu C, Brocca-Cofano E, Raehtz KD, et al
    Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers.
    PLoS Pathog. 2016;12:e1005879.
    PubMed     Text format     Abstract available


  49. RAGHWANI J, Rose R, Sheridan I, Lemey P, et al
    Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection.
    PLoS Pathog. 2016;12:e1005894.
    PubMed     Text format     Abstract available


  50. JARDINE JG, Sok D, Julien JP, Briney B, et al
    Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.
    PLoS Pathog. 2016;12:e1005905.
    PubMed     Text format     Abstract available


  51. KLASSE PJ, LaBranche CC, Ketas TJ, Ozorowski G, et al
    Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.
    PLoS Pathog. 2016;12:e1005864.
    PubMed     Text format     Abstract available


  52. CARIAS AM, Allen SA, Fought AJ, Kotnik Halavaty K, et al
    Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract.
    PLoS Pathog. 2016;12:e1005885.
    PubMed     Text format     Abstract available


  53. ZEVIN AS, Xie IY, Birse K, Arnold K, et al
    Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract.
    PLoS Pathog. 2016;12:e1005889.
    PubMed     Text format     Abstract available


  54. DA SILVA SANTOS C, Tartour K, Cimarelli A
    A Novel Entry/Uncoating Assay Reveals the Presence of at Least Two Species of Viral Capsids During Synchronized HIV-1 Infection.
    PLoS Pathog. 2016;12:e1005897.
    PubMed     Text format     Abstract available


    August 2016
  55. FENG Y, Tran K, Bale S, Kumar S, et al
    Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies.
    PLoS Pathog. 2016;12:e1005767.
    PubMed     Text format     Abstract available


  56. DEMERS KR, Makedonas G, Buggert M, Eller MA, et al
    Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection.
    PLoS Pathog. 2016;12:e1005805.
    PubMed     Text format     Abstract available


  57. PLOQUIN MJ, Madec Y, Casrouge A, Huot N, et al
    Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset.
    PLoS Pathog. 2016;12:e1005774.
    PubMed     Text format     Abstract available


  58. LASKEY SB, Pohlmeyer CW, Bruner KM, Siliciano RF, et al
    Evaluating Clonal Expansion of HIV-Infected Cells: Optimization of PCR Strategies to Predict Clonality.
    PLoS Pathog. 2016;12:e1005689.
    PubMed     Text format     Abstract available


  59. PINKEVYCH M, Cromer D, Tolstrup M, Grimm AJ, et al
    Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission.
    PLoS Pathog. 2016;12:e1005745.
    PubMed     Text format     Abstract available


  60. PINKEVYCH M, Kent SJ, Tolstrup M, Lewin SR, et al
    Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5-8 Days.
    PLoS Pathog. 2016;12:e1005740.
    PubMed     Text format    


  61. HILL AL, Rosenbloom DI, Siliciano JD, Siliciano RF, et al
    Insufficient Evidence for Rare Activation of Latent HIV in the Absence of Reservoir-Reducing Interventions.
    PLoS Pathog. 2016;12:e1005679.
    PubMed     Text format    


  62. JARDINE JG, Sok D, Julien JP, Briney B, et al
    Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.
    PLoS Pathog. 2016;12:e1005815.
    PubMed     Text format     Abstract available


  63. YORK A, Kutluay SB, Errando M, Bieniasz PD, et al
    The RNA Binding Specificity of Human APOBEC3 Proteins Resembles That of HIV-1 Nucleocapsid.
    PLoS Pathog. 2016;12:e1005833.
    PubMed     Text format     Abstract available


  64. BADIA R, Pujantell M, Riveira-Munoz E, Puig T, et al
    The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells.
    PLoS Pathog. 2016;12:e1005829.
    PubMed     Text format     Abstract available


  65. PACE M, Williams J, Kurioka A, Gerry AB, et al
    Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.
    PLoS Pathog. 2016;12:e1005782.
    PubMed     Text format     Abstract available


  66. TAY MZ, Liu P, Williams LD, McRaven MD, et al
    Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses.
    PLoS Pathog. 2016;12:e1005817.
    PubMed     Text format     Abstract available


    July 2016

  67. Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.
    PLoS Pathog. 2016;12:e1005778.
    PubMed     Text format     Abstract available


  68. BOYD DF, Sharma A, Humes D, Cheng-Mayer C, et al
    Adapting SHIVs In Vivo Selects for Envelope-Mediated Interferon-alpha Resistance.
    PLoS Pathog. 2016;12:e1005727.
    PubMed     Text format     Abstract available


  69. RADEMEYER C, Korber B, Seaman MS, Giorgi EE, et al
    Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
    PLoS Pathog. 2016;12:e1005742.
    PubMed     Text format     Abstract available


  70. HOFFMANN M, Pantazis N, Martin GE, Hickling S, et al
    Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.
    PLoS Pathog. 2016;12:e1005661.
    PubMed     Text format     Abstract available


  71. FROMENTIN R, Bakeman W, Lawani MB, Khoury G, et al
    CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
    PLoS Pathog. 2016;12:e1005761.
    PubMed     Text format     Abstract available


  72. MUIR R, Metcalf T, Tardif V, Takata H, et al
    Altered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection.
    PLoS Pathog. 2016;12:e1005777.
    PubMed     Text format     Abstract available


    June 2016
  73. ABDEL-MOHSEN M, Chavez L, Tandon R, Chew GM, et al
    Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation.
    PLoS Pathog. 2016;12:e1005677.
    PubMed     Text format     Abstract available


  74. LIU F, Fan X, Auclair S, Ferguson M, et al
    Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection.
    PLoS Pathog. 2016;12:e1005663.
    PubMed     Text format     Abstract available


  75. BENDJENNAT M, Saffarian S
    The Race against Protease Activation Defines the Role of ESCRTs in HIV Budding.
    PLoS Pathog. 2016;12:e1005657.
    PubMed     Text format     Abstract available


  76. DHARAN A, Talley S, Tripathi A, Mamede JI, et al
    KIF5B and Nup358 Cooperatively Mediate the Nuclear Import of HIV-1 during Infection.
    PLoS Pathog. 2016;12:e1005700.
    PubMed     Text format     Abstract available


  77. FRANCIS AC, Marin M, Shi J, Aiken C, et al
    Time-Resolved Imaging of Single HIV-1 Uncoating In Vitro and in Living Cells.
    PLoS Pathog. 2016;12:e1005709.
    PubMed     Text format     Abstract available


  78. ARRODE-BRUSES G, Goode D, Kleinbeck K, Wilk J, et al
    A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin alpha4beta7 and Fails to Prevent Mucosal Transmission of SHIV-SF162P3.
    PLoS Pathog. 2016;12:e1005720.
    PubMed     Text format     Abstract available


    May 2016
  79. TULLY DC, Ogilvie CB, Batorsky RE, Bean DJ, et al
    Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus.
    PLoS Pathog. 2016;12:e1005619.
    PubMed     Text format     Abstract available


  80. DELVIKS-FRANKENBERRY KA, Nikolaitchik OA, Burdick RC, Gorelick RJ, et al
    Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation.
    PLoS Pathog. 2016;12:e1005646.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: